Protagonist Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline include PTG-300, PTG-200, and PN-943 The company was founded by Mark L. 

CEO
Dinesh V. Patel
CEODinesh V. Patel
Employees
118
Employees118
Headquarters
Newark, California
HeadquartersNewark, California
Founded
2006
Founded2006
Employees
118
Employees118

PTGX Key Statistics

Market cap
414.76M
Market cap414.76M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
798.35K
Average volume798.35K
High today
$8.79
High today$8.79
Low today
$8.27
Low today$8.27
Open price
$8.27
Open price$8.27
Volume
658.19K
Volume658.19K
52 Week high
$38.11
52 Week high$38.11
52 Week low
$6.91
52 Week low$6.91

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

PTGX Earnings

-$0.93
-$0.62
-$0.31
-$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 2, After Hours
ActualExpected Nov 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.